Navigation Links
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Trius Therapeutics, Inc. - TSRX
Date:7/31/2013

and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.

CONTACT:
Robert Willoughby
Pomerantz Grossman Hufford Dahlstrom & Gross LLP
212-661-1100 ext. 237
rswilloughby@pomlaw.com


'/>"/>
SOURCE Pomerantz Grossman Hufford Dahlstrom & Gross LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty
2. Adamis Pharmaceuticals CEO Provides Update for Shareholders
3. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.
4. 3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders
5. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and the May 6, 2013 Lead Plaintiff Deadline
6. Hadasit Bio-Holdings CEO Letter to Shareholders
7. Medifirst Solutions, Inc. Announces Further Update To Shareholders
8. Letter from Alliqua CEO, Dave Johnston, to Shareholders
9. TPI to Hold 2012 Shareholder Annual Meeting on May 8, 2013 In New York City
10. EastBridge Investment Group Announces Completion of its Merger with Cellular Biomedicine Group - Shareholder Conference Call to be held February 8th
11. Cell Therapeutics, Inc.s (CTI) Board of Directors Approves Amendment of Shareholder Rights Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... PROVIDENCE, N.J. , Sept. 2, 2014   ... for MassBio,s 20th Annual Golf Classic, a major fundraiser ... event will be held on September 5 at the ... . The MassBioEd Foundation supports ... through educational programs, workforce development, and lifelong learning. ...
(Date:9/2/2014)... nanowires could be used for detailed studies of what ... important for pharmaceuticals research, among other applications. A group ... to make artificial cell membranes form across a large ... All communication between the interior of a cell and ... membrane is a surface layer that holds the cell ...
(Date:9/2/2014)... -- Persistence Market Research ( http://www.persistencemarketresearch.com/ ) ... and Life Sciences: North America ... market for pharmaceutical, biopharma and life sciences is estimated at ... grow at a CAGR of 9.1% from 2014 to ... million in 2019. Browse the full Global ...
(Date:9/2/2014)... 2014 Myriant Corporation, a global ... a distribution agreement with Azelis Group, a specialty ... bio-succinic acid in the Nordics, Benelux, France, Iberia, ... in the industrial and base chemicals markets. , ... a far-reaching chemical portfolio with extensive distribution networks ...
Breaking Biology Technology:Linde helps fund STEM education in Massachusetts 2Linde helps fund STEM education in Massachusetts 3Nano-forests to reveal secrets of cells 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5Myriant and Azelis Sign European Distribution Agreement for Bio-Succinic Acid 2
... N.J., June 12 BioNeutral announced today the,results ... anthrax,spores on contact. This chemical technology is designed ... in conjunction with any suspected anthrax,exposure. "The Ygiene(TM) ... in as little as 15 seconds," said Dr. ...
... June 12 GenVault Corporation today,announces Paul J. ... Inc.,has joined its Board of Directors. Mr. Mirabella ... imaging with GE Healthcare where he held,leadership roles ... this substantial background in diagnostics and the healthcare,market, ...
... BRUNSWICK, N.J., June 12 Senesco,Technologies, Inc. ("Senesco" ... announced,that the Company will be presenting at the ... Annual International Convention,which is being held at the ... Galton, Chief Executive Officer of Senesco, will deliver ...
Cached Biology Technology:BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism 2Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVault's Board of Directors 2Senesco Technologies to Present at BIO 2008 Business Forum 2
(Date:9/2/2014)... always true that digital distribution of media will ... means, at least when file sizes are large. ... in Yale,s Journal of Industrial Ecology ... for consoles such as PlayStation3. Researchers found that ... greenhouse gas emissions than game files downloaded over ...
(Date:9/2/2014)... New research suggests that professional baseball pitchers with poor ... days in a single season because of injury than are ... back and pelvis. , In the study, 347 pitchers were ... tilt in their pelvis as they raised a leg to ... miss at least 30 days cumulative, not consecutive ...
(Date:9/2/2014)... A new study published in the September issue ... , identifies a novel strategy to diagnose the ... before irreversible structural damage has occurred. This advance ... diabetes on the endothelium of retinal vessels. Using ... to distinguish the early molecular development of diabetic ...
Breaking Biology News(10 mins):In pro baseball pitchers, weak core linked to more missed days 2In pro baseball pitchers, weak core linked to more missed days 3Molecular probes permit doctors to detect diabetic retinopathy before vision fails 2
... presents research on the genetic make-up and biology of ... better diagnosis and treatment of the diarrhea disease giardiasis, ... may also bring an understanding of several vital biological ... parasite that exists all over the world and causes ...
... GMES Programme approved the transition to Phase-2 of Segment ... of the programme by the ESA Council at ministerial ... 2 of 116%, giving a total amount of 500 ... ESA to confirm the development of the first three ...
... Now Fully Supports M2SYS Fingerprint Technology to ... Accurately Verify Check Casher Identity, ... biometric,technology research and development firm, announced today its partnership,with ... solutions, to integrate the M2SYS Bio-Plugin(TM) fingerprint,solution into TeraCash, ...
Cached Biology News:New Swedish research hope for millions of sufferers 2M2SYS Technology Partners with TeraCorp Enterprises to Provide Added Security Within Check Cashing Solution 2
... a chemiluminescent signal enhancing reagent that ... the signal obtained with all ECL ... Plus is derived from a powerful, ... or chemiluminescent substrate enhancers, ChemiLucent™ Plus ...
... Best: DASGIPs Process Control integrates Process ... comprehensive documentation for cultivation processes. A ... pH, dissolved oxygen, temperature and agitation ... Profiles, e.g. constant or scheduled media ...
... PEP-165 is an 18 amino acid synthetic peptide whose sequences ... peptide is (amino to carboxy terminus): S(21) - S - M ... D - E - A - I - D - K ... C(39). This peptide may be used for neutralization and ...
... for quantitative assays using recombinant proteins/antibodies ... the flexible and powerful Paraflo microfluidic ... sequences can be synthesized on-chip and ... custom sequence design. These microarrays are ...
Biology Products: